Literature DB >> 12483173

The protective action of chlorpromazine on the spinal cord of rabbits submitted to ischemia and reperfusion is dose-dependent.

A Amin Sader1, J Barbieri-Neto, S Lopes Sader, S Assis Mazzetto, P Alves, J C Vanni.   

Abstract

BACKGROUND: Chlorpromazine (CPZ), at high doses, has been shown to protect the central nervous system in experimental models of ischemia and reperfusion. The purpose of this study was: 1) to investigate the protection afforded by different doses of CPZ on the spinal cord of rabbits submitted to ischemia and reperfusion. 2) to correlate the motor impairment of the hind limbs and the percentage of damaged neurons in the anterior horns of the lumbar spinal cord in treated and untreated animals.
METHODS: Seventy-two New Zealand white rabbits were divided into 6 equal groups (n=12): sham operation, control and 4 study groups. Spinal cord ischemia was obtained by clamping the abdominal aorta caudally to the renal arteries for 30 min, after which it was released and the animals were observed for a period of 48 hrs. The control animals received 3 ml/kg of 0.9% NaCl, i.v., 10 min before aorta clamping. The experimental animals received CPZ, i.v., at doses of 2, 1 and 0.5 mg/kg, 10 min before aorta clamping. In one group 1 mg/kg of CPZ was given 10 min before aorta clamping and the same dose was repeated 2 hrs after the beginning of reperfusion. The spinal cord of the control animals and of those who received one CPZ dose of 2 mg/kg was processed for light microscopy examination.
RESULTS: Motor scores of the hind limbs, graded 0 to 4, obtained 48 hrs after the beginning of reperfusion showed that CPZ was effective at doses of 2 and 1 mg/kg. No significant difference was observed with the dose of 0.5 mg/kg. However, the best results were obtained with the dose of 2 mg/kg administered in a fractionated manner. Histological examination revealed that at the dose of 2 mg/kg, CPZ protected a significant number of neuronal cells and that motor recovery hardly occurred when the number of damaged neurons exceeded 50%.
CONCLUSIONS: 1) The neuroprotective action of CPZ is dose-dependent in the ischemic spinal cord of rabbits. The lower protective dose is 1 mg/kg, which is too high for human beings. 2) There is an inverse correlation between motor recovery and percentage of damaged neurons, and the critical point seems to be between 30% and 50%.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12483173

Source DB:  PubMed          Journal:  J Cardiovasc Surg (Torino)        ISSN: 0021-9509            Impact factor:   1.888


  5 in total

1.  Neuroprotection by Chlorpromazine and Promethazine in Severe Transient and Permanent Ischemic Stroke.

Authors:  Xiaokun Geng; Fengwu Li; James Yip; Changya Peng; Omar Elmadhoun; Jiamei Shen; Xunming Ji; Yuchuan Ding
Journal:  Mol Neurobiol       Date:  2016-11-28       Impact factor: 5.590

2.  Chlorpromazine protects against apoptosis induced by exogenous stimuli in the developing rat brain.

Authors:  Jing Wu; Rongrong Song; Wuqi Song; Yujun Li; Qingmeng Zhang; Yang Chen; Yingmei Fu; Wenjuan Fang; Jindong Wang; Zhaohua Zhong; Hong Ling; Liming Zhang; Fengmin Zhang
Journal:  PLoS One       Date:  2011-07-14       Impact factor: 3.240

3.  Reduced Apoptotic Injury by Phenothiazine in Ischemic Stroke through the NOX-Akt/PKC Pathway.

Authors:  Yanna Tong; Kenneth B Elkin; Changya Peng; Jiamei Shen; Fengwu Li; Longfei Guan; Yu Ji; Wenjing Wei; Xiaokun Geng; Yuchuan Ding
Journal:  Brain Sci       Date:  2019-12-15

4.  Rapid Intervention of Chlorpromazine and Promethazine for Hibernation-Like Effect in Stroke: Rationale, Design, and Protocol for a Prospective Randomized Controlled Trial.

Authors:  Shuyu Lv; Wenbo Zhao; Gary B Rajah; Chaitu Dandu; Lipeng Cai; Zhe Cheng; Honglian Duan; Qingqing Dai; Xiaokun Geng; Yuchuan Ding
Journal:  Front Neurol       Date:  2021-03-17       Impact factor: 4.003

5.  Stress protein expression in early phase spinal cord ischemia/reperfusion injury.

Authors:  Shanyong Zhang; Dankai Wu; Jincheng Wang; Yongming Wang; Guoxiang Wang; Maoguang Yang; Xiaoyu Yang
Journal:  Neural Regen Res       Date:  2013-08-25       Impact factor: 5.135

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.